benidipine has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, Y; Jesmin, S; Kitabatake, A; Miyauchi, T; Sakuma, I | 1 |
| Harano, Y; Hasegawa, M; Kanazawa, A; Suzuki, M | 1 |
1 trial(s) available for benidipine and Insulin Resistance
| Article | Year |
|---|---|
Improvement of insulin resistance in essential hypertension by long-acting Ca antagonist benidipine.
Topics: Apolipoproteins; Arteriosclerosis; Blood Glucose; Blood Platelets; Blood Pressure; Calcium; Calcium Channel Blockers; Catecholamines; Dihydropyridines; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Intracellular Fluid; Male; Middle Aged; Treatment Outcome | 1999 |
1 other study(ies) available for benidipine and Insulin Resistance
| Article | Year |
|---|---|
The calcium channel antagonist benidipine reduces plasma and cardiac endothelin-1 levels in type II diabetic rat model.
Topics: Age Factors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Dihydropyridines; Disease Models, Animal; Down-Regulation; Endothelin-1; Insulin Resistance; Male; Myocardium; Rats; Rats, Inbred OLETF; Rats, Long-Evans | 2004 |